Literature DB >> 8633495

Hyperventilation and esophageal dysmotility in patients with noncardiac chest pain.

R A Cooke1, A Anggiansah, J Wang, J B Chambers, W Owen.   

Abstract

OBJECTIVES: Hyperventilation is known to cause esophageal spasm, but the importance of this interaction in clinical practice is unknown. In the present study, we report the effects of hyperventilation provocation on esophageal motility in a consecutive series of patients with noncardiac chest pain.
METHODS: In a prospective observational study design, 46 consecutive patients with normal coronary angiograms were studied. Esophageal motility was recorded at rest and after voluntary over-breathing at 40 breaths/min for 3 min.
RESULTS: Hyperventilation was associated with a significant fall in mean distal peristaltic amplitude [66 (SD 28) to 55 (SD 24) mm Hg, p <0.001] and mean duration [2.9 (SD 0.7) to 2.6 (SD 0.9) s,p = 0.02]. It induced diffuse spasm in two (4%) patients, and nonspecific motility disorders in 10 (22%). Chest pain was reproduced in seven (15%) patients, but in none did this coincide with an important change in peristaltic amplitude, duration, or frequency.
CONCLUSION: Hyperventilation has important effects on esophageal motility, and manometrists should be aware of these before recommending that anxious patients overbreathe to help relaxation during clinical studies. Although overbreathing is a common source of dysmotility, it rarely produces chest pain via its effects on the esophagus.

Entities:  

Mesh:

Year:  1996        PMID: 8633495

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  2 in total

1.  Noncardiac chest pain: epidemiology, natural course and pathogenesis.

Authors:  Ronnie Fass; Sami R Achem
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

2.  Established and Emerging Treatment Options for Functional Heartburn and Chest Pain.

Authors:  Jan Tack; Tim Vanuytsel; Ans Pauwels
Journal:  Curr Treat Options Gastroenterol       Date:  2016-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.